Brain Tumor Research and Treatment | Ivy Brain Tumor Center

3 Things You Need to Know

Doctor speaking with his patient in the office

Standard of care

Isn't working

The current standard of care for patients with aggressive brain tumors like glioblastoma is not curative and most patients experience tumor progression after treatment. Learn More

Researcher looking in microscope

You need

Individualized treatment

Unlike other cancers such as breast or lung, brain tumors are extremely genetically heterogeneous and require a treatment regimen that is tailored to your individual tumor. Learn More

Family photo of a husband, wife, and their two young boys

Time

Is of the essence

Conventional clinical trials can take months to inform patients if a therapy is working. This is time you simply do not have to invest. Learn More

Phase 0 Trials

Ivy Phase 0 clinical trials allow patients to receive individualized treatment in a fraction of the time and costs associated with traditional drug research and development.

Benefits of an Ivy Phase 0 Trial

Saves Valuable Time

Drug effects on a patient’s tumor are directly measured within 10 days of surgery. If an experimental regimen is ineffective, the patient can transition to another type of therapy without losing time or options.

Personalizes Treatment

Genetic testing with unprecedented depth allows us to match tumors to new combination drug regimens. Due to the speed in which our trials open and close, we are able to test more new therapies than any other clinical trials program.

Tests New Drugs

Every Ivy Center drug combination tests new mechanisms never before trialed in brain tumor patients. As a nonprofit organization, there is no conflict of interest or hidden agenda in selecting which drugs to include in our program.

Dr. Patricia Tagle-Levy

PATIENT EXPERIENCE

Patricia: Clinical Trial Patient

When Patricia’s glioblastoma came back after her first surgery, she and her husband both knew it was time to start looking at alternative treatment options. After extensive research, they discovered the hope they were looking for was actually right in their backyard at the Ivy Center in Phoenix.

Read Full Story

View Open Trials

Gliomas

Common subtypes include astrocytoma, oligodendroglioma, glioblastoma, and gliosarcoma

Brain Metastases

Also known as ‘secondary’ brain tumors; originate from cancer in another part of the body

Meningiomas

Primary brain tumors derived from the lining of the brain, known as the meninges

Ependymomas

Arises from the ependymal cells that line the ventricles of the brain and the center of the spinal cord

Craniopharyngiomas

Arises from small nests of cells near the pituitary stalk at the base of the skull, near the pituitary gland, third ventricle, and optic nerve

Pineal-Region Tumors

Occurs in the pineal region of the brain that may or may not involve the pineal gland

COMMUNITY OF CAREGIVERS

Ivy Brain Tumor Center Builds On Innovative Clinical Trial Program by Appointing New Chief Medical Officer

May 23, 2023

The Ivy Brain Tumor Center and Barrow Neurological Institute are pleased to announce the addition of Yoshie Umemura, MD, as the new Chief Medical Officer of the Ivy Brain Tumor Center and Division Chief of Neuro-Oncology and the William and Joan Shapiro Chair of Neuro-Oncology at Barrow Neurological Institute.

Team stacking hands to show teamwork

Making a Difference on Glioblastoma Awareness Day 2023

Ivy Center

Glioblastoma Awareness Day (GBM Day) is dedicated to increasing public awareness of glioblastoma brain cancer.

Fighting Brain Cancer – A Glioblastoma Story

April 25, 2023
Posted in Patient Stories

Jenn Ortiz, a mother of two, is celebrating three years of survivorship this August! Her journey with brain cancer began at the Ivy Center when she was diagnosed with glioblastoma. Despite the challenges she’s faced, Jenn remains optimistic, inspiring those around her with her perseverance and undeniable sense of humor. Read her full story here.

Chicago skyline aerial drone view from above, lake Michigan and city of Chicago downtown skyscrapers cityscape, Illinois, USA

Ivy Brain Tumor Center Announces Interim Results of Two Clinical Trials Targeting High-Grade Glioma

June 2, 2023

The Ivy Center proudly announces our participation in the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting for two Phase 0 clinical trials of infigratinib and niraparib in recurrent high-grade glioma and newly-diagnosed glioblastoma.

Patient with a brain tumor, receiving liquid CSF biopsy

Ivy Brain Tumor Center Implements New Liquid Biopsy Program to Provide Glioblastoma Patients More Personalized Care

September 7, 2022

The Ivy Brain Tumor Center announced its initiation of a ‘Liquid Biopsy’ program to obtain real-time insights into how a patient’s brain tumor is responding to experimental treatment.

Digital tablet being held in front of MRI machine

Robust Glioblastoma Clinical Trials Program Offers Brain Cancer Patients New Treatment Options

February 18, 2023
Posted in Clinical Trials

Our team of brain tumor experts have compiled everything you need to know about our clinical trials, including the rationale behind the novel drugs and devices we’re investigating as well as some of the initial results we’re seeing in brain cancer patients.

Brain tumor research HQ to be built on St. Joseph’s Phoenix campus

July 29, 2021
Source: Phoenix Business Journal

The Ivy Brain Tumor Center at Barrow Neurological Institute plans to build its 75,000-square-foot global headquarters on the campus of St. Joseph’s Hospital and Medical Center in Phoenix.

Am I Eligible?

Submit a Trial Screening Request today and an Ivy Navigator will contact you within 48 hours to complete the initial patient assessment.

Determine your Eligibility